Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (70 ops.)
Latest filing published 08 Jul 2026 for Puma Biotechnology, INC., €318k.
Filing timeline
BuySaleAlan H. Auerbach
Insider track record
Disclosed buys
0
Disclosed sells
70
Signal history
Alan H. Auerbach: trading record in brief
Alan H. Auerbach (chief executive) discloses dealings in 2 companies, chiefly Puma Biotechnology, Inc. and SRKP 4 Inc. Between 3 July 2009 and 6 July 2026, the trades on record add up to 85 filings.
Every open-market trade on record is a sale: 70 sales worth €5.1M. Other entries cover 14 share grants. So far in 2026, the count stands at no purchases and 3 sales.
The newest entry dates from 8 July 2026: an open-market sale of €318k, in Puma Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan H. Auerbach
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations85 total
44,058 shares@ US$8.2630.076% mcap7.7% of flowCommon StockSEC:0001437749-26-023079:0
159,778 shares0Common StockSEC:0001437749-26-004948:0
18,012 shares@ US$5.880.7% of flowCommon StockSEC:0001437749-26-000924:1
16,938 shares@ US$5.8442.0% of flowCommon StockSEC:0001437749-26-000924:0
21,580 shares@ US$3.540.5% of flowCommon StockSEC:0001437749-25-022547:1
25,592 shares@ US$3.5331.9% of flowCommon StockSEC:0001437749-25-022547:0
198,399 shares0Common StockSEC:0001437749-25-003454:0
33,841 shares@ US$3.15172.5% of flowCommon StockSEC:0001437749-25-000359:0
21,920 shares@ US$3.70111.8% of flowCommon StockSEC:0001437749-24-023014:0
18,885 shares@ US$3.26851.4% of flowCommon StockSEC:0001437749-24-022061:0
6,577 shares0Common StockSEC:0001437749-24-008575:0
160,796 shares0Common StockSEC:0001437749-24-004211:0
41,396 shares@ US$4.48594.1% of flowCommon StockSEC:0001437749-24-000770:0
60,698 shares@ US$3.31124.4% of flowCommon StockSEC:0001437749-23-019519:0
186,403 shares0Common StockSEC:0001437749-23-003371:0
27,241 shares@ US$4.17792.6% of flowCommon StockSEC:0001437749-23-000512:0
568,181 shares@ US$4.4057.3% of flowCommon StockSEC:0001437749-22-028940:0
1,251 shares@ US$4.49780.1% of flowCommon StockSEC:0001437749-22-028564:0
1,242 shares@ US$2.250.1% of flowCommon StockSEC:0001437749-22-026038:0
1,260 shares@ US$2.33540.1% of flowCommon StockSEC:0001437749-22-023673:0
1,254 shares@ US$2.58960.1% of flowCommon StockSEC:0001437749-22-021980:0
1,247 shares@ US$2.890.1% of flowCommon StockSEC:0001437749-22-018958:0
26,140 shares@ US$2.63151.6% of flowCommon StockSEC:0001437749-22-016852:0
1,200 shares@ US$1.94410.1% of flowCommon StockSEC:0001437749-22-014429:0
1,263 shares@ US$2.32010.1% of flowCommon StockSEC:0001437749-22-010922:0
25 of 85 declarations
